Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus nuclear antigen 1-immunoglobulin A in human serum.

about

Development of a time-resolved fluorescence immunoassay for Epstein-Barr virus nuclear antigen 1-immunoglobulin A in human serum.

Item

http://www.wikidata.org/entity/Q41130447

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Development of a time-resolved ...... munoglobulin A in human serum.

@en

type

Item

label

Development of a time-resolved ...... munoglobulin A in human serum.

@en

prefLabel

Development of a time-resolved ...... munoglobulin A in human serum.

@en

P1476

Development of a time-resolved ...... munoglobulin A in human serum.

@en

P2093

Juan-Juan Chen

http://www.w3.org/2001/XMLSchema#string

Ming Li

http://www.w3.org/2001/XMLSchema#string

Qian-Ni Liang

http://www.w3.org/2001/XMLSchema#string

Ying-Song Wu

http://www.w3.org/2001/XMLSchema#string

Zhi-Ning Dong

http://www.w3.org/2001/XMLSchema#string

P2860

Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus

Global cancer statistics, 2002

Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia.

Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for fie

Two-step Epstein-Barr virus immunoglobulin A enzyme-linked immunosorbent assay system for serological screening and confirmation of nasopharyngeal carcinoma

Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma.

Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells.

Dried-blood sampling for epstein-barr virus immunoglobulin G (IgG) and IgA serology in nasopharyngeal carcinoma screening.

Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma.

Evaluation of antibodies against different Epstein-Barr virus nuclear antigen 1 peptides in diagnosis of nasopharyngeal carcinoma.

P304

1940-1945

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMV.24247

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tiancai Liu

P577

2015-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26129643

http://www.w3.org/2001/XMLSchema#string